Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome
- PMID: 35593530
- PMCID: PMC9541175
- DOI: 10.1111/cen.14757
Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting 8%-13% of reproductive-aged women. The aetiology of the syndrome is complex, with genetic susceptibility, androgen exposure in early life and adiposity related dysfunction leading to perturbance in hypothalamic-ovarian function. PCOS clinical features are heterogeneous, with manifestations arising even in early adolescence, developing into multisystem reproductive, metabolic and psychological manifestations in adulthood. In this review, we will discuss challenges in the diagnosis of PCOS and understanding of the natural history of PCOS.
Keywords: challenges; diagnosis; natural history; phenotypes; polycystic ovary syndrome.
© 2022 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Polycystic ovary syndrome in adolescents.Int J Obes (Lond). 2008 Jul;32(7):1035-41. doi: 10.1038/ijo.2008.61. Epub 2008 May 6. Int J Obes (Lond). 2008. PMID: 18458678 Review.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Development of polycystic ovary syndrome: involvement of genetic and environmental factors.Int J Androl. 2006 Feb;29(1):278-85; discussion 286-90. doi: 10.1111/j.1365-2605.2005.00623.x. Epub 2005 Dec 22. Int J Androl. 2006. PMID: 16390494 Review.
-
Natural History of Polycystic Ovary Syndrome and New Advances in the Epidemiology.Semin Reprod Med. 2021 Jul;39(3-04):94-101. doi: 10.1055/s-0041-1735211. Epub 2021 Aug 31. Semin Reprod Med. 2021. PMID: 34464984
-
Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.Mol Metab. 2020 May;35:100937. doi: 10.1016/j.molmet.2020.01.001. Epub 2020 Feb 5. Mol Metab. 2020. PMID: 32244180 Free PMC article.
Cited by
-
Assessment of the Validity and Quality of Polycystic Ovarian Syndrome (PCOS) Screening Tools Available for Women Globally: A Systematic Review.Clin Pract. 2024 Aug 23;14(5):1625-1649. doi: 10.3390/clinpract14050131. Clin Pract. 2024. PMID: 39311281 Free PMC article. Review.
-
Role of EGFR expressed on the granulosa cells in the pathogenesis of polycystic ovarian syndrome.Front Endocrinol (Lausanne). 2022 Nov 11;13:971564. doi: 10.3389/fendo.2022.971564. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36440230 Free PMC article.
-
The PCOS Phenotypes in Unselected Populations (P-PUP) study: participant clinical features and data harmonization on analysis of individual participant data.BMC Med. 2025 Jul 15;23(1):420. doi: 10.1186/s12916-025-04221-9. BMC Med. 2025. PMID: 40660246 Free PMC article.
-
Mitochondrial Dysfunction in Polycystic Ovary Syndrome.Reprod Sci. 2023 May;30(5):1435-1442. doi: 10.1007/s43032-022-01100-z. Epub 2022 Oct 11. Reprod Sci. 2023. PMID: 36221022 Review.
-
Stanniocalcin Protein Expression in Female Reproductive Organs: Literature Review and Public Cancer Database Analysis.Endocrinology. 2024 Aug 27;165(10):bqae110. doi: 10.1210/endocr/bqae110. Endocrinology. 2024. PMID: 39186548 Free PMC article. Review.
References
-
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta‐analysis. Hum Reprod. 2016;31:2841‐2855. - PubMed
-
- Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41‐47. - PubMed
-
- Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care. 2019;42:560‐567. - PubMed
-
- Joham A, Teede H, Ranasinha S, Zoungas S, Boyle J. Infertility and assisted reproductive technology use in women with polycystic ovary syndrome: data from the Australian longitudinal women's health study. J Women's Health. 2015;24:299‐307. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical